ARVEE — Arvee Laboratories (India) Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.78bn
- IN₹1.74bn
- IN₹384.87m
Annual cashflow statement for Arvee Laboratories (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 36.4 | 34.5 | 61.7 | 18.3 | 28.7 |
| Depreciation | |||||
| Non-Cash Items | -0.031 | -0.13 | 0.764 | -2.34 | -3.84 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -43.3 | -50.8 | -53.9 | 5.69 | -38.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 17.1 | 6.81 | 29.3 | 36.6 | -2.06 |
| Capital Expenditures | -22.9 | -23.6 | -14.8 | -25.9 | -18.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 16.9 | 24.2 | 2.26 | 4.23 | 5.38 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.04 | 0.593 | -12.6 | -21.6 | -13.2 |
| Financing Cash Flow Items | -4.92 | -3.15 | -2.86 | -1.88 | -1.51 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 45.2 | -60.6 | -24.2 | -1.88 | -1.18 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 56.3 | -53.2 | -7.46 | 13.1 | -16.4 |